MicroRNA-26b-5p Suppresses the Proliferation of Tongue Squamous Cell Carcinoma Via Targeting Proline Rich 11 (PRR11)

Liang Yi,Ying Liu,Anji Xu,Sha Li,Hailin Zhang,Mingjing Peng,Zan Li,Huayi Ren,Jie Dai,Chenhui Luo,Yazhou Xiao,Xiao Zhou,Ying Long
DOI: https://doi.org/10.1080/21655979.2021.1969832
2021-01-01
Bioengineered
Abstract:MicroRNAs (miRNAs) have been proved to be involved in many biological processes during tumorigenesis and progression, including cell proliferation and cell cycle progression. However, the potential role of miR-26b-5p in tongue squamous cell carcinoma (TSCC) remains unclear. In the present study, we demonstrated that miR-26b-5p was decreased in TSCC tissues in both TCGA-TSCC subset and eight paired samples from TSCC patients, while Proline Rich 11 (PRR11) was obviously increased. Transfection of miR-26b-5p mimics inhibited CALL7 cell proliferation by arresting the cells at the S/G2 transition. Meanwhile, miR-26b-5p inhibitor had the opposite biological functions. The results of luciferase activity and RNA-pulldown assays indicated that miR-26b-5p directly targeted the PRR11 3' -untranslated region in CAL27 cells. Furthermore, the effects of miR-26b-5p on cell cycle regulation were reversed after treatment with siRNA against PRR11. In summary, our findings indicate that miR-26b-5p induce cell cycle arrest in TSCC by targeting PRR11. Hence, targeting miR-26b-5p could be a promising therapeutic strategy for the treatment of TSCC.
What problem does this paper attempt to address?